Altimmune (ALT) PT Lowered to $11 at Citizens on Increased Dilutive Shares in 10-Q Filing

May 14, 2026 4:45 AM

Citizens analyst Jonathan Wolleben lowered the price target on Altimmune (NASDAQ: ALT) to $11.00 (from $14.00) while maintaining a Market ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found